A large multi-centre European study validates high-sensitivity C-reactive protein (hsCRP) as a clinical biomarker for the diagnosis of diabetes subtypes

Diabetologia

Volumn 54, Issue 11, 2011, Pages 2801-2810

  Thanabalasingham, G ^a,b   Shah, N ^c   Vaxillaire, M ^d   Hansen, T ^e,f   Tuomi, T ^g,h   Gasperikova D ⁱ   Szopa, M ^j   Tjora, E ^k,l   James, T J ^c   Kokko, P ^g   Loiseleur, F ^m   Andersson, E ^e   Gaget, S ^d   Isomaa, B ^h   Nowak, N ^j   Raeder, H ^k,l   Stanik, J ^i,n   Njolstad, P R ^k,l   Malecki, M T ^j   Klimes, I ⁱ   Groop, L ^g,o   Pedersen, O ^e,p,q   Froguel, P ^d,r   McCarthy, M I ^a,b,s   Gloyn, A L ^a,b   Owen, K R ^a,b   more..

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b CHURCHILL HOSPITAL   (United Kingdom)

^c JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^d UNIV LILLE   (France)

^e UNIVERSITY OF COPENHAGEN   (Denmark)

^f UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^g HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^h UNIVERSITY OF HELSINKI   (Finland)

ⁱ INSTITUTE OF CHEMISTRY   (Slovakia)

^j JAGIELLONIAN UNIVERSITY   (Poland)

^k UNIVERSITY OF BERGEN   (Norway)

^l HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^m INSTITUT PASTEUR DE LILLE   (France)

ⁿ Faculty of Medicine of Comenius University and University Hospital Bratislava   (Slovakia)

^o LUND UNIVERSITY HOSPITAL   (Sweden)

^p HAGEDORN RESEARCH INSTITUTE   (Denmark)

^q AARHUS UNIVERSITY   (Denmark)

^r IMPERIAL COLLEGE LONDON   (United Kingdom)

^s UNIVERSITY OF OXFORD   (United Kingdom)

more..

Author keywords

Biomarker; High sensitivity C reactive protein; hsCRP; Maturity onset diabetes of the young; MODY

Indexed keywords

C REACTIVE PROTEIN;

ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DENMARK; DIABETES MELLITUS; DIAGNOSTIC ACCURACY; EUROPE; FINLAND; FRANCE; GENOTYPE PHENOTYPE CORRELATION; GLUCOKINASE MATURITY ONSET DIABETES OF THE YOUNG; HEPATOCYTE NUCLEAR FACTOR 1 ALPHA MATURITY ONSET DIABETES OF THE YOUNG; HEPATOCYTE NUCLEAR FACTOR 4 ALPHA MATURITY ONSET DIABETES OF THE YOUNG; HUMAN; MAJOR CLINICAL STUDY; MISSENSE MUTATION; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; NORWAY; POLAND; PRIORITY JOURNAL; PROTEIN ANALYSIS; RECEIVER OPERATING CHARACTERISTIC; SCORING SYSTEM; SLOVAKIA; SWEDEN; UNITED KINGDOM; VALIDATION PROCESS;

ADULT; AGE OF ONSET; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; DIABETES MELLITUS, TYPE 2; EUROPE; GLUCOKINASE; HEPATOCYTE NUCLEAR FACTOR 1-ALPHA; HEPATOCYTE NUCLEAR FACTOR 4; HETEROZYGOTE; HUMANS; META-ANALYSIS AS TOPIC; MIDDLE AGED; MOLECULAR DIAGNOSTIC TECHNIQUES; MUTATION; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 80054692207     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-011-2261-y     Document Type: Article

References (28)

1. MI McCarthy 2010 Genomics, type 2 diabetes, and obesity N Engl J Med 363 2339 2350 21142536 10.1056/NEJMra0906948 1:CAS:528:DC%2BC3cXhsFGkt7zO
2. AP Reiner MJ Barber Y Guan, et al. 2008 Polymorphisms of the HNF1A gene encoding hepatocyte nuclear factor-1 alpha are associated with C-reactive protein Am J Hum Genet 82 1193 1201 18439552 10.1016/j.ajhg.2008.03.017 1:CAS:528:DC%2BD1cXlvFeqtL4%3D
3. PM Ridker G Pare A Parker, et al. 2008 Loci related to metabolic-syndrome pathways including LEPR, HNF1A, IL6R, and GCKR associate with plasma C-reactive protein: the Womens Genome Health Study Am J Hum Genet 82 1185 1192 18439548 10.1016/j.ajhg.2008.03.015 1:CAS:528:DC%2BD1cXlvFeqt7c%3D
4. C Toniatti A Demartis P Monaci A Nicosia G Ciliberto 1990 Synergistic trans-activation of the human C-reactive protein promoter by transcription factor HNF-1 binding at two distinct sites EMBO J 9 4467 4475 2265613 1:CAS:528:DyaK3MXls1Oiug%3D%3D (Pubitemid 120026004)
5. T Nishikawa K Hagihara S Serada, et al. 2008 Transcriptional complex formation of c-Fos, STAT3, and hepatocyte NF-1 alpha is essential for cytokine-driven C-reactive protein gene expression J Immunol 180 3492 3501 18292576 1:CAS:528:DC%2BD1cXit1Okt7g%3D
6. DQ Shih M Bussen E Sehayek, et al. 2001 Hepatocyte nuclear factor-1alpha is an essential regulator of bile acid and plasma cholesterol metabolism Nat Genet 27 375 382 11279518 10.1038/86871 1:CAS:528:DC%2BD3MXjtFShs7g%3D (Pubitemid 32268417)
7. KR Owen G Thanabalasingham TJ James, et al. 2010 Assessment of high-sensitivity C-reactive protein levels as diagnostic discriminator of maturity-onset diabetes of the young due to HNF1A mutations Diabetes Care 33 1919 1924 20724646 10.2337/dc10-0288 1:CAS:528:DC%2BC3cXht1OmurjK
8. BM Shields S Hicks MH Shepherd K Colclough AT Hattersley S Ellard 2010 Maturity-onset diabetes of the young (MODY): how many cases are we missing? Diabetologia 53 2465 2467 10.1007/s00125-010-1799-4
9. J Kropff MP Selwood MI McCarthy AJ Farmer KR Owen 2011 Prevalence of monogenic diabetes in young adults: a community-based, cross-sectional study in Oxfordshire, UK Diabetologia 54 1261 1263 21350841 10.1007/s00125-011-2090-z 1:STN:280:DC%2BC3Mvhtlyktg%3D%3D
10. ER Pearson BJ Starkey RJ Powell FM Gribble PM Clark AT Hattersley 2003 Genetic cause of hyperglycaemia and response to treatment in diabetes Lancet 362 1275 1281 14575972 10.1016/S0140-6736(03)14571-0 1:CAS:528:DC%2BD3sXot1Cjt7s%3D (Pubitemid 37324255)
11. G Thanabalasingham A Pal AJ Farmer S Ellard MI McCarthy KR Owen 2010 Extending criteria for genetic testing increases diagnosis of maturity-onset diabetes of the young Diabetologia 53 S63 (abstract 137)
12. CC Lee AI Adler MS Sandhu, et al. 2009 Association of C-reactive protein with type 2 diabetes: prospective analysis and meta-analysis Diabetologia 52 1040 1047 19326095 10.1007/s00125-009-1338-3 1:CAS:528:DC%2BD1MXlt1GqtLk%3D
13. PM Ridker 2003 Clinical application of C-reactive protein for cardiovascular disease detection and prevention Circulation 107 363 369 12551853 10.1161/01.CIR.0000053730.47739.3C (Pubitemid 36158034)
14. LE Moses D Shapiro B Littenberg 1993 Combining independent studies of a diagnostic test into a summary ROC curve: data-analytic approaches and some additional considerations Stat Med 12 1293 1316 8210827 1:STN:280: DyaK2c%2FitlGkug%3D%3D (Pubitemid 23230833)
15. LW Harries S Ellard A Stride NG Morgan AT Hattersley 2006 Isomers of the TCF1 gene encoding hepatocyte nuclear factor-1 alpha show differential expression in the pancreas and define the relationship between mutation position and clinical phenotype in monogenic diabetes Hum Mol Genet 15 2216 2224 16760222 10.1093/hmg/ddl147 1:CAS:528:DC%2BD28XmsVejtrs%3D (Pubitemid 43985513)
16. C Bellanne-Chantelot C Carette JP Riveline, et al. 2008 The type and the position of HNF1A mutation modulate age at diagnosis of diabetes in patients with maturity-onset diabetes of the young (MODY)-3 Diabetes 57 503 508 18003757 10.2337/db07-0859 1:CAS:528:DC%2BD1cXhvVOktLk%3D
17. H Passing W Bablok 1983 A new biometrical procedure for testing the equality of measurements from two different analytical methods. Application of linear regression procedures for method comparison studies in clinical chemistry, part I J Clin Chem Clin Biochem 21 709 720 6655447 1:STN:280:DyaL2c%2FovFGgtQ%3D%3D (Pubitemid 14208512)
18. R Murphy S Ellard AT Hattersley 2008 Clinical implications of a molecular genetic classification of monogenic beta-cell diabetes Nat Clin Pract Endocrinol Metabol 4 200 213 10.1038/ncpendmet0778 1:CAS:528: DC%2BD1cXjsFClurY%3D (Pubitemid 351430925)
19. A Dehghan J Dupuis M Barbalic, et al. 2011 Meta-analysis of genome-wide association studies in >80,000 subjects identifies multiple loci for C-reactive protein levels Circulation 123 731 738 21300955 10.1161/ CIRCULATIONAHA.110.948570 1:CAS:528:DC%2BC3MXisVWrtb4%3D
20. S Ellard C Bellanne-Chantelot AT Hattersley 2008 Best practice guidelines for the molecular genetic diagnosis of maturity-onset diabetes of the young Diabetologia 51 546 553 18297260 10.1007/s00125-008-0942-y 1:STN:280: DC%2BD1c7pt12itQ%3D%3D
21. ER Pearson SF Boj AM Steele, et al. 2007 Macrosomia and hyperinsulinaemic hypoglycaemia in patients with heterozygous mutations in the HNF4A gene PLoS Med 4 e118 17407387 10.1371/journal.pmed.0040118 (Pubitemid 46658777)
22. A Stride M Vaxillaire T Tuomi, et al. 2002 The genetic abnormality in the beta cell determines the response to an oral glucose load Diabetologia 45 427 435 11914749 10.1007/s00125-001-0770-9 1:CAS:528:DC%2BD38XitVeisr8%3D (Pubitemid 34267366)
23. A Pal AJ Farmer C Dudley, et al. 2009 Evaluation of serum 1,5 anhydroglucitol levels as a clinical test to differentiate subtypes of diabetes Diabetes Care 33 252 257 19933992 10.2337/dc09-1246
24. PH Whincup CM Nightingale CG Owen, et al. 2010 Early emergence of ethnic differences in type 2 diabetes precursors in the UK: the Child Heart and Health Study in England (CHASE Study) PLoS Med 7 e1000263 20421924 10.1371/journal. pmed.1000263
25. ES Ford WH Giles GL Myers N Rifai PM Ridker DM Mannino 2003 C-reactive protein concentration distribution among US children and young adults: findings from the National Health and Nutrition Examination Survey, 1999-2000 Clin Chem 49 1353 1357 12881452 10.1373/49.8.1353 1:CAS:528:DC%2BD3sXlvF2ntrk%3D (Pubitemid 36900622)
26. DJ Freeman J Norrie MJ Caslake, et al. 2002 C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study Diabetes 51 1596 1600 11978661 10.2337/diabetes.51.5.1596 1:CAS:528:DC%2BD38XjtlGmur8%3D (Pubitemid 34826630)
27. AG Tabak M Kivimaki EJ Brunner, et al. 2010 Changes in C-reactive protein levels before type 2 diabetes and cardiovascular death: the Whitehall II study Eur J Endocrinol 163 89 95 20573938 10.1530/EJE-10-0277 1:CAS:528: DC%2BC3cXpsFeisr4%3D
28. KG Alberti P Zimmet J Shaw 2006 Metabolic syndrome-a new world-wide definition. A Consensus Statement from the International Diabetes Federation Diabet Med 23 469 480 16681555 10.1111/j.1464-5491.2006.01858.x 1:STN:280:DC%2BD283lslGgsQ%3D%3D